Transfusion therapy: its role in the anemias.
Potentially hazardous and at best supportive, transfusion therapy obligates the clinician to make careful clinical judgments regarding anticipated benefits versus possible complications. Ways to maximize benefit and minimize risk are outlined.
D000740:Anemia / Q000628:therapy*; D001787:Blood Group Incompatibility / Q000209:etiology; D001788:Blood Grouping and Crossmatching; D003676:Deferoxamine / Q000008:administration & dosage; D017707:Erythrocyte Transfusion; D005615:Freezing; D006486:Hemosiderosis / Q000209:etiology; D006525:Hepatitis, Viral, Human / Q000209:etiology; D006801:Humans; D007167:Immunotherapy; D007501:Iron / Q000097:blood; D007502:Iron Chelating Agents / Q000008:administration & dosage; D065227:Transfusion Reaction
D007502:Iron Chelating Agents; D007501:Iron; D003676:Deferoxamine